
Leigh C. Maier
Examiner (ID: 4240, Phone: (571)272-0656 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1693, 1614, 1623, 1621 |
| Total Applications | 1395 |
| Issued Applications | 727 |
| Pending Applications | 80 |
| Abandoned Applications | 594 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16954870
[patent_doc_number] => 11058697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Inhibiting inflammation with milk oligosaccharides
[patent_app_type] => utility
[patent_app_number] => 15/998799
[patent_app_country] => US
[patent_app_date] => 2018-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3303
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15998799
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/998799 | Inhibiting inflammation with milk oligosaccharides | Aug 15, 2018 | Issued |
Array
(
[id] => 14069119
[patent_doc_number] => 20190083447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => REDUCTION OF GASTROINTESTINAL TRACT COLONISATION BY CAMPYLOBACTER
[patent_app_type] => utility
[patent_app_number] => 16/055935
[patent_app_country] => US
[patent_app_date] => 2018-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16055935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/055935 | REDUCTION OF GASTROINTESTINAL TRACT COLONISATION BY CAMPYLOBACTER | Aug 5, 2018 | Abandoned |
Array
(
[id] => 16341652
[patent_doc_number] => 20200306302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => TREATING AND INHIBITING LEUKEMIA WITH NK-92 CELLS
[patent_app_type] => utility
[patent_app_number] => 16/636266
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636266
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/636266 | TREATING AND INHIBITING LEUKEMIA WITH NK-92 CELLS | Aug 2, 2018 | Abandoned |
Array
(
[id] => 19593229
[patent_doc_number] => 12151047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Hydrogel for tissue engineering and bioprinting
[patent_app_type] => utility
[patent_app_number] => 16/641056
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 30
[patent_no_of_words] => 11714
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641056
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641056 | Hydrogel for tissue engineering and bioprinting | Jul 24, 2018 | Issued |
Array
(
[id] => 13549141
[patent_doc_number] => 20180326118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => IMMOBILISED BIOLOGICAL ENTITIES
[patent_app_type] => utility
[patent_app_number] => 16/042945
[patent_app_country] => US
[patent_app_date] => 2018-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16042945
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/042945 | IMMOBILISED BIOLOGICAL ENTITIES | Jul 22, 2018 | Abandoned |
Array
(
[id] => 13823917
[patent_doc_number] => 20190015443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH 2-O AND, OR 3-O DESULFATED HEPARINOIDS
[patent_app_type] => utility
[patent_app_number] => 16/041444
[patent_app_country] => US
[patent_app_date] => 2018-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16041444
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/041444 | TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH 2-O AND, OR 3-O DESULFATED HEPARINOIDS | Jul 19, 2018 | Abandoned |
Array
(
[id] => 16596570
[patent_doc_number] => 20210023101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => POTENTIATION OF ANTIBIOTIC EFFECT
[patent_app_type] => utility
[patent_app_number] => 16/630174
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630174
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630174 | POTENTIATION OF ANTIBIOTIC EFFECT | Jul 18, 2018 | Abandoned |
Array
(
[id] => 13533583
[patent_doc_number] => 20180318334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => DRUG CONTAINING CATIONIZED CHITOSAN
[patent_app_type] => utility
[patent_app_number] => 16/034710
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034710
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034710 | DRUG CONTAINING CATIONIZED CHITOSAN | Jul 12, 2018 | Abandoned |
Array
(
[id] => 16252119
[patent_doc_number] => 20200261493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => FUCOSYLATED CHONDROITIN SULFATE OLIGOSACCHARIDE AND METHOD FOR RAPIDLY PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/762147
[patent_app_country] => US
[patent_app_date] => 2018-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762147
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762147 | Mixture of fucosylated chondroitin sulfate oligosaccharides and method for rapidly producing the same | Jul 10, 2018 | Issued |
Array
(
[id] => 13522139
[patent_doc_number] => 20180312612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => METHOD FOR PREPARING SUGAMMADEX SODIUM
[patent_app_type] => utility
[patent_app_number] => 16/031083
[patent_app_country] => US
[patent_app_date] => 2018-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16031083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/031083 | METHOD FOR PREPARING SUGAMMADEX SODIUM | Jul 9, 2018 | Abandoned |
Array
(
[id] => 13778111
[patent_doc_number] => 20190002594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => Chitosan-Derived Compositions
[patent_app_type] => utility
[patent_app_number] => 16/028160
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028160
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/028160 | Chitosan-Derived Compositions | Jul 4, 2018 | Abandoned |
Array
(
[id] => 16398848
[patent_doc_number] => 20200339706
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-10-29
[patent_title] => Chitosan-Derived Compositions
[patent_app_type] => utility
[patent_app_number] => 16/028221
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028221
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/028221 | Chitosan-derived compositions | Jul 4, 2018 | Issued |
Array
(
[id] => 16398848
[patent_doc_number] => 20200339706
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-10-29
[patent_title] => Chitosan-Derived Compositions
[patent_app_type] => utility
[patent_app_number] => 16/028221
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028221
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/028221 | Chitosan-derived compositions | Jul 4, 2018 | Issued |
Array
(
[id] => 14403579
[patent_doc_number] => 20190167633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY
[patent_app_type] => utility
[patent_app_number] => 16/026886
[patent_app_country] => US
[patent_app_date] => 2018-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16026886
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/026886 | COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY | Jul 2, 2018 | Abandoned |
Array
(
[id] => 13493149
[patent_doc_number] => 20180298117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Heparan Sulfate Having High 3-O-Sulfation Rate in Glucosamine Residues
[patent_app_type] => utility
[patent_app_number] => 16/018487
[patent_app_country] => US
[patent_app_date] => 2018-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16018487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/018487 | Heparan sulfate having high 3-O-sulfation rate in glucosamine residues | Jun 25, 2018 | Issued |
Array
(
[id] => 16786086
[patent_doc_number] => 10988498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs
[patent_app_type] => utility
[patent_app_number] => 16/011055
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27475
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011055
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/011055 | Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs | Jun 17, 2018 | Issued |
Array
(
[id] => 18526374
[patent_doc_number] => 11713360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Method for producing cellulose nanofibers
[patent_app_type] => utility
[patent_app_number] => 16/607870
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4386
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607870
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607870 | Method for producing cellulose nanofibers | May 31, 2018 | Issued |
Array
(
[id] => 13424957
[patent_doc_number] => 20180264021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
[patent_app_type] => utility
[patent_app_number] => 15/988368
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15988368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/988368 | Treatment of papulopustular rosacea with ivermectin | May 23, 2018 | Issued |
Array
(
[id] => 15646649
[patent_doc_number] => 20200085854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => COMPOSITION FOR USE IN THE TREATMENT OF EXTRAOESOPHAGEAL GASTRIC REFLUX SYMPTOMS
[patent_app_type] => utility
[patent_app_number] => 16/617368
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617368
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617368 | COMPOSITION FOR USE IN THE TREATMENT OF EXTRAOESOPHAGEAL GASTRIC REFLUX SYMPTOMS | May 17, 2018 | Abandoned |
Array
(
[id] => 13548787
[patent_doc_number] => 20180325941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => COMPOSITION FOR REDUCING ABSORPTION OF DIETARY FAT
[patent_app_type] => utility
[patent_app_number] => 15/977840
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15977840
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/977840 | COMPOSITION FOR REDUCING ABSORPTION OF DIETARY FAT | May 10, 2018 | Abandoned |